Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Acta Obstet Gynecol Scand ; 103(9): 1820-1828, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38943224

RESUMEN

INTRODUCTION: Women with systemic lupus erythematosus (SLE) have a higher risk for fetal and maternal complications. We aimed to investigate maternal and fetal complications in pregnant women with SLE compared to a high-risk pregnancy cohort (HR) from a tertiary university center and a standard-risk general population (SR) from the Austrian Birth Registry. MATERIAL AND METHODS: In this retrospective data analysis, we compared the incidence of fetal/neonatal and maternal complications of pregnancies and deliveries of women with SLE to age, body mass index and delivery date-matched high-risk pregnancies from the same department, a progressive tertiary obstetric center and to a group of women, who represent pregnancies with standard obstetric risk from the Austrian Birth Registry. RESULTS: One hundred women with SLE were compared to 300 women with high-risk pregnancies and 207 039 women with standard-risk pregnancies. The incidence of composite maternal complications (preeclampsia, Hemolysis, Elevated Liver enzymes and Low Platelets [HELLP] syndrome, pregnancy-related hypertension, gestational diabetes mellitus, maternal death, thromboembolic events) was significantly higher in the SLE as compared to the SR group (28% vs. 6.28% SLE vs. SR, p = 0.001). There was no difference between the SLE and the HR groups (28% vs. 29.6% SLE vs. HR group, p = 0.80). The incidence of composite fetal complications (preterm birth before 37 weeks of gestation, stillbirths, birthweight less than 2500 g, fetal growth restriction, large for gestational age, admission to neonatal intensive care unit, 5-min Apgar <7) was also higher in the SLE than in the SR group (55% vs. 25.54% SLE vs. SR p < 0.001) while the higher incidence of adverse fetal outcome was detected in the HR than in the SLE group (55% vs. 75% SLE vs. HR group, p = 0.0005). CONCLUSIONS: Although composite fetal risk is higher in the SLE group than in the general population, it is still significantly lower as compared to high-risk pregnant women at a tertiary obstetric center. Prepregnancy counseling of women with SLE should put fetal and maternal risk in perspective, not only in relation to healthy, low risk cohorts, but also compared to mixed HR populations.


Asunto(s)
Lupus Eritematoso Sistémico , Complicaciones del Embarazo , Resultado del Embarazo , Sistema de Registros , Humanos , Femenino , Embarazo , Lupus Eritematoso Sistémico/epidemiología , Lupus Eritematoso Sistémico/complicaciones , Adulto , Resultado del Embarazo/epidemiología , Austria/epidemiología , Estudios Retrospectivos , Complicaciones del Embarazo/epidemiología , Recién Nacido , Embarazo de Alto Riesgo , Incidencia
2.
Infection ; 52(4): 1615-1620, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38446279

RESUMEN

BACKGROUND: Listeria monocytogenes is a bacterial pathogen known for causing listeriosis, a foodborne illness with a wide spectrum of clinical presentations ranging from mild gastroenteritis to severe invasive disease, particularly affecting immunocompromised individuals, pregnant women, newborns, and the elderly. Successful treatment of patients with recurring listeria episodes due to colonised foreign material is often challenging, typically requiring a combination of antimicrobial treatment and surgical removal. CASE PRESENTATION: Here, we present a particularly complex case of chronic invasive listeriosis with a total of six relapses. After extensive investigations, the patient's ICD device was identified as the focus of infection. CONCLUSION: The confirmation of relapses through cgMLST analysis highlights the persistence of Listeria monocytogenes and the potential for recurrence even after apparent resolution of symptoms in patients with foreign material. It emphasises the necessity for a comprehensive assessment to identify and mitigate the risk of relapses, thereby ensuring optimal management and outcomes.


Asunto(s)
Bacteriemia , Listeria monocytogenes , Listeriosis , Embolia Pulmonar , Humanos , Listeriosis/tratamiento farmacológico , Listeriosis/microbiología , Listeriosis/diagnóstico , Listeria monocytogenes/aislamiento & purificación , Bacteriemia/microbiología , Bacteriemia/tratamiento farmacológico , Embolia Pulmonar/microbiología , Embolia Pulmonar/tratamiento farmacológico , Recurrencia , Desfibriladores Implantables/efectos adversos , Masculino , Femenino , Antibacterianos/uso terapéutico , Anciano
3.
Chaos ; 34(1)2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-38285721

RESUMEN

We consider reaction-diffusion systems and other related dissipative systems on unbounded domains with the aim of showing that self-similarity, besides the well-known exact self-similar solutions, can also occur asymptotically in two different forms. For this, we study systems on the unbounded real line that have the property that their restriction to a finite domain has a Lyapunov function (and a gradient structure). In this situation, the system may reach local equilibrium on a rather fast time scale, but on unbounded domains with an infinite amount of mass or energy, it leads to a persistent mass or energy flow for all times; hence, in general, no true equilibrium is reached globally. In suitably rescaled variables, however, the solutions to the transformed system converge to so-called non-equilibrium steady states that correspond to asymptotically self-similar behavior in the original system.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...